Skip to content

Relationship Between Adipose Tissue Distribution and Arterial Stiffness in HFpEF

Relationship Between Adipose Tissue Distribution and Arterial Stiffness in Heart Failure With Preserved Ejection Fraction(HFpEF)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05095688
Enrollment
50
Registered
2021-10-27
Start date
2020-09-21
Completion date
2022-12-31
Last updated
2021-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Stiffness, Heart Failure With Preserved Ejection Fraction, Lipid Disorder

Brief summary

Heart failure with preserved ejection fraction (HFpEF) was considered as a heterogeneous disease with multi-organ and multi-system design, which is related to various complications, such as hypertension, obesity and arteriosclerosis. Studies have found that hypertension and obesity are respectively associated with increased arterial stiffness. However, there is still no research investigating the the relationship between lipids distribution and arterial stiffness in HFpEF patients.

Detailed description

Before the 21st century, Heart failure with preserved ejection fraction (HFpEF) was considered as a disease with simple diastolic dysfunction, but after the 21st century, HFpEF was considered as a heterogeneous disease with multi-organ and multi-system design, which is related to various complications, such as hypertension, obesity and arteriosclerosis. Other studies have found that hypertension and obesity are respectively associated with increased arterial stiffness. However, there is still no research investigating the the relationship between lipids distribution and arterial stiffness in HFpEF patients.

Interventions

None listed

Sponsors

Chongqing Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. Adult aged \>=18years old; 2. Diagnosed with HFpEF. Diagnostic criteria including: 1. left ventricular ejection fraction ≥50%; 2. with the symptoms and/or signs of heart failure; 3. BNP≥35 pg/mL and/or NTproBNP≥125 pg/mL; 4. at least one additional criterion: relevant structural heart disease(LVH and/or LAE) or diastolic dysfunction

Exclusion criteria

1. LVEF less than 45% at any time; 2. Severe liver failure; 3/Other causes of shortness of breath, such as severe pulmonary disease or severe chronic obstructive pulmonary disease; 4.Primary pulmonary hypertension; 5.Severe valvular disease of the left heart; 6.Chronically bedridden or incapacitated; 7.Age \<18 years old.

Design outcomes

Primary

MeasureTime frameDescription
Arterial stiffness1 day after admissionThe baPWV(cm/s) of HFpEF patients
adipose tissue distribution1 day after admissionThe visceral fat area(cm\^2) in HFpEF patients

Countries

China

Contacts

Primary ContactDongying Zhang, doctor
zdy.chris@qq.com+8613608398395

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026